App-Quantinova.ai

The cardiac-specific Troponin-I Predicts the Coronary Artery Involvement in Rheumatoid Arthritis

Dong Li - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Complex calcified coronary artery lesions

Prednisolone

Combining High Sensitivity Troponin I and T Measurements Improves Prediction of Long-Term Clinical Outcomes in Patients With Atrial Fibrillation - An Aristotle Substudy

Agneta Siegbahn - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myocardial infarction

N/A

Serial Measurement of an Ultrasensitive Cardiac Troponin-I Predicts Cardiovascular Outcomes and Ventricular Remodeling in Chronic Heart Failure

Jackie Szymonifka - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Systolic dysfunction

N/A

Substitution of Adult Cardiac Troponin I, cTnI, With the Fetal Isoform, ssTnI, in Adult Mice Augments Metabolic Remodeling and Reduces Both Decompensatory Hypertrophy and Contractile Dysfunction During Chronic Pressure Overload

Domenico M Taglieri - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Diastolic dysfunction

Palmitic acid

Myocardial Biomarker Testing With Troponin I: Are We Ordering Too Many Studies?

Heidi T May - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myocardial infarction

N/A

Atrial Natriuretic Peptide as a Marker for Early Rule-Out of Acute Myocardial Infarction

Julia Searle - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Myocardial infarction

N/A

Activation of Sirtuin 3 Protects the Heart From Ischemia-Reperfusion Injury by Increased Cellular Antioxidant Defenses

Qing Ma - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Ischemia-reperfusion injury

Superoxide dismutase

MicroRNA 1825 Acts as a Master Regulator Inducing Proliferation of Adult Cardiomyocytes and Regenerates Ischemic Myocardium

Shazia Durrani - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

High-Sensitive Cardiac Troponin-I and NT-proBNP Improve Predictive Ability of Risk Stratification Model for Sudden Cardiac Death in End-Stage Renal Disease

Makoto Suzuki - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Microvascular complications of diabetes 1

N/A

Annexin-A1 Biomimetic Peptide Attenuates Myocardial Ischemia-Reperfusion Injury via Increased Sirtuin-3

Qing Ma - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Ischemia-reperfusion injury

Cardioplegic

Early Cardiac Remodeling in Response to Chemotherapy in Early Stage Breast Cancer Patients With Low Cardiac Risk: A Prospective Cardiac Magnetic Resonance Imaging Study

David Inyangetor - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

Trastuzumab

Etiology of Gender Differences in Cardiac Troponin I Concentrations

Tanja Zeller - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

N/A

Gastric Bypass Surgery is Associated with a Marked Reduction in Circulating High Sensitivity Cardiac Troponin I Concentrations: Comparison with Intensive Lifestyle Intervention

Torbjorn Omland - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Congestive heart failure

N/A

Causes for Increased Cardiac Troponin I Using Gender-Specific 99th Percentiles From a High Sensitivity Assay in a US Population

Stephen W. Smith - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Coronary Artery Disease

N/A

Correlation of Left Ventricular Ejection Fraction with In-hospital Outcomes After First Attack of Non-ST Segment Elevation Myocardial Infarction

Mirza Md Nazrul Islam - Angioplasty Summit-TCTAP , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Manual Thrombus Aspiration Reduces Myocardial Necrosis During Primary Percutaneous Coronary Intervention (PPCI) in Patients with ST-Elevation Myocardial Infarction (STEMI).

A.P.M. Sohrabuzzaman - Angioplasty Summit-TCTAP , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Highly-sensitive Cardiac Troponin-I and Beta-2-Glycoprotein-I IgA Antibodies Inform the Utility of Screening and Follow-up Non-invasive Coronary Atherosclerosis Evaluation and Optimize Cardiovascular Risk Assessment in Rheumatoid Arthritis

Sarah Ormseth - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Rheumatoid arthritis

N/A

Unexpected Role of Adenosine-Monophosphate Activated Protein Kinase in Doxorubicin Cardiotoxicity and Metformin-Mediated Cardioprotection

Jaclyn Del Pozzo - Heart Failure Society of America (HFSA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 2 diabetes mellitus

Doxorubicin

Diagnostic Utility of Troponin-I in Patients with Cardiac Amyloidosis

Nour Tashtish - Heart Failure Society of America (HFSA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hypertrophic cardiomyopathy

N/A

MANAGEMENT OF ST ELEVATION MYOCARDIAL INFARCTION IN THE SETTING OF A MYOCARDIAL BRIDGE: IS THERE ANY LIGHT AT THE END OF THE TUNNEL?

Ahmed Ibrahim - American College of Cardiology (ACC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Filters

350 Abstracts